Bayesian Phase II Platform Trial Tests Novel Targeted Regimens for Brain Lymphoma
A multicentre phase II platform trial protocol establishes sequential testing of zanubrutinib monotherapy and combinations for relapsed primary central nervous ...
A multicentre phase II platform trial protocol establishes sequential testing of zanubrutinib monotherapy and combinations for relapsed primary central nervous ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.